Why medicines must be tested in the developing world

“Whatever ethical issues exist in rich countries are amplified in poor ones, where people may not know their rights, where regulatory authorities might be weaker and where there is often a history of exploitation and racism. Yet, such concerns notwithstanding, poor countries should be conducting more clinical trials not fewer.”

via Financial Times